* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 1027 | CDKN1B | C1970712 | Multiple Endocrine Neoplasia, Type IV | 0.402197814273705 | BEFREE;CTD_human;ORPHANET |
| 1027 | CDKN1B | C1458155 | Mammary Neoplasms | 0.239359681644245 | BEFREE;CTD_human;LHGDN |
| 1027 | CDKN1B | C0033578 | Prostatic Neoplasms | 0.233842699557305 | BEFREE;CTD_human;GAD;LHGDN |
| 1027 | CDKN1B | C2239176 | Liver carcinoma | 0.226222126485924 | BEFREE;CTD_human;GAD;LHGDN |
| 1027 | CDKN1B | C0025267 | Multiple Endocrine Neoplasia Type 1 | 0.214298469424775 | BEFREE;GAD;ORPHANET |
| 1027 | CDKN1B | C0032019 | Pituitary Neoplasms | 0.207337755261807 | BEFREE;CTD_human;GAD;LHGDN |
| 1027 | CDKN1B | C0206754 | Neuroendocrine Tumors | 0.203557092817453 | BEFREE;CTD_human;LHGDN |
| 1027 | CDKN1B | C0032000 | Pituitary Adenoma | 0.203296721410557 | BEFREE;HPO |
| 1027 | CDKN1B | C0007095 | Carcinoid Tumor | 0.20328236603324 | BEFREE;HPO;LHGDN |
| 1027 | CDKN1B | C0919267 | ovarian neoplasm | 0.20328236603324 | BEFREE;CTD_human;LHGDN |
| 1027 | CDKN1B | C0001206 | Acromegaly | 0.203231208875927 | BEFREE;GAD;HPO |
| 1027 | CDKN1B | C0024121 | Lung Neoplasms | 0.203007639249027 | BEFREE;CTD_human;LHGDN |
| 1027 | CDKN1B | C0282612 | Prostatic Intraepithelial Neoplasias | 0.203007639249027 | BEFREE;CTD_human;LHGDN |
| 1027 | CDKN1B | C0038356 | Stomach Neoplasms | 0.202732912464814 | CTD_human;LHGDN |
| 1027 | CDKN1B | C0023903 | Liver neoplasms | 0.201648360705279 | BEFREE;CTD_human |
| 1027 | CDKN1B | C0020502 | Hyperparathyroidism | 0.200824180352639 | BEFREE;HPO |
| 1027 | CDKN1B | C0262587 | Parathyroid Adenoma | 0.200824180352639 | BEFREE;HPO |
| 1027 | CDKN1B | C0033375 | Prolactinoma | 0.200549453568426 | BEFREE;HPO |
| 1027 | CDKN1B | C0021841 | Intestinal Neoplasms | 0.200274726784213 | BEFREE;CTD_human |
| 1027 | CDKN1B | C0025500 | Mesothelioma | 0.200274726784213 | BEFREE;CTD_human |
| 1027 | CDKN1B | C0011991 | Diarrhea | 0.2 | HPO |
| 1027 | CDKN1B | C0014868 | Esophagitis | 0.2 | HPO |
| 1027 | CDKN1B | C0020437 | Hypercalcemia | 0.2 | HPO |
| 1027 | CDKN1B | C0021670 | insulinoma | 0.2 | HPO |
| 1027 | CDKN1B | C0022665 | Kidney Neoplasm | 0.2 | CTD_human |
| 1027 | CDKN1B | C0030920 | Peptic Ulcer | 0.2 | HPO |
| 1027 | CDKN1B | C0034885 | Rectal Neoplasms | 0.2 | CTD_human |
| 1027 | CDKN1B | C0036920 | Sezary Syndrome | 0.2 | CTD_human |
| 1027 | CDKN1B | C0042138 | Uterine Neoplasms | 0.2 | CTD_human |
| 1027 | CDKN1B | C0043515 | Zollinger-Ellison syndrome | 0.2 | HPO |
| 1027 | CDKN1B | C0079487 | Helicobacter Infections | 0.2 | CTD_human |
| 1027 | CDKN1B | C0151468 | Thyroid Gland Follicular Adenoma | 0.2 | HPO |
| 1027 | CDKN1B | C0206667 | Adrenal Cortical Adenoma | 0.2 | HPO |
| 1027 | CDKN1B | C0206669 | Hepatocellular Adenoma | 0.2 | CTD_human |
| 1027 | CDKN1B | C0206731 | Angiofibroma | 0.2 | HPO |
| 1027 | CDKN1B | C0235986 | Growth hormone excess | 0.2 | HPO |
| 1027 | CDKN1B | C0241961 | Angiomyolipoma of kidney | 0.2 | HPO |
| 1027 | CDKN1B | C0262527 | intermittent abdominal pain | 0.2 | HPO |
| 1027 | CDKN1B | C0263454 | Chloracne | 0.2 | CTD_human |
| 1027 | CDKN1B | C0271844 | Parathyroid hyperplasia | 0.2 | HPO |
| 1027 | CDKN1B | C0338078 | Non-Functioning Pituitary Gland Neoplasm | 0.2 | HPO |
| 1027 | CDKN1B | C0857973 | Increased serum parathyroid hormone | 0.2 | HPO |
| 1027 | CDKN1B | C1403035 | Subcutaneous lipomas | 0.2 | HPO |
| 1027 | CDKN1B | C1864903 | Hyperinsulinaemic hypoglycaemia | 0.2 | HPO |
| 1027 | CDKN1B | C1864954 | Hyperinsulinemia, fasting | 0.2 | HPO |
| 1027 | CDKN1B | C3808022 | Abdominal pain, episodic | 0.2 | HPO |
| 1027 | CDKN1B | C4018860 | Pituitary growth hormone cell adenoma | 0.2 | HPO |
| 1027 | CDKN1B | C0027051 | Myocardial Infarction | 0.0829564820917142 | BEFREE;GAD;RGD |
| 1027 | CDKN1B | C0017665 | Membranous glomerulonephritis | 0.0802747267842131 | BEFREE;RGD |
| 1027 | CDKN1B | C0020542 | Pulmonary Hypertension | 0.08 | RGD |
| 1027 | CDKN1B | C0028754 | Obesity | 0.08 | RGD |
| 1027 | CDKN1B | C0149940 | Sciatic Neuropathy | 0.08 | RGD |
| 1027 | CDKN1B | C0270612 | Leukoencephalopathies | 0.08 | RGD |
| 1027 | CDKN1B | C0006142 | Malignant neoplasm of breast | 0.0313442066916804 | BEFREE;GAD |
| 1027 | CDKN1B | C0024299 | Lymphoma | 0.027017596083929 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0007137 | Squamous cell carcinoma | 0.0256951193201762 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0001418 | Adenocarcinoma | 0.0171704979842092 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0023418 | leukemia | 0.0169101265773133 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0025202 | melanoma | 0.0164118301661998 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0009404 | Colorectal Neoplasms | 0.0160715908473568 | GAD;LHGDN |
| 1027 | CDKN1B | C0007134 | Renal Cell Carcinoma | 0.0147634694609212 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0376358 | Malignant neoplasm of prostate | 0.0146387087436177 | BEFREE;GAD |
| 1027 | CDKN1B | C1140680 | Malignant neoplasm of ovary | 0.0139582301059317 | BEFREE;GAD |
| 1027 | CDKN1B | C0027627 | Neoplasm Metastasis | 0.0134041909171729 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0678222 | Breast Carcinoma | 0.0120879785053764 | BEFREE |
| 1027 | CDKN1B | C0596263 | Carcinogenesis | 0.0101648910158847 | BEFREE |
| 1027 | CDKN1B | C0027662 | Multiple Endocrine Neoplasia | 0.00981029631972445 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0017636 | Glioblastoma | 0.0082130927717585 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0040136 | Thyroid Neoplasm | 0.0078728534529155 | GAD;LHGDN |
| 1027 | CDKN1B | C0017638 | Glioma | 0.0071141856349061 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0600139 | Prostate carcinoma | 0.0068681696053275 | BEFREE |
| 1027 | CDKN1B | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.006839458850693 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0242379 | Malignant neoplasm of lung | 0.0064624177518546 | BEFREE;GAD |
| 1027 | CDKN1B | C0014175 | Endometriosis | 0.00623884812495415 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0007133 | Carcinoma, Papillary | 0.0060152784980537 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0030297 | Pancreatic Neoplasm | 0.00596412134074105 | BEFREE;GAD;LHGDN |
| 1027 | CDKN1B | C0007873 | Uterine Cervical Neoplasm | 0.0054658249296275 | LHGDN |
| 1027 | CDKN1B | C0026764 | Multiple Myeloma | 0.00520545352273165 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0035335 | Retinoblastoma | 0.00520545352273165 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0026640 | Mouth Neoplasms | 0.00513994098810175 | GAD;LHGDN |
| 1027 | CDKN1B | C0023467 | Leukemia, Myelocytic, Acute | 0.00493072673851855 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.00493072673851855 | BEFREE;LHGDN |
| 1027 | CDKN1B | C1956346 | Coronary Artery Disease | 0.004814057046576 | GAD |
| 1027 | CDKN1B | C0005695 | Bladder Neoplasm | 0.00438127317009235 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0005684 | Malignant neoplasm of urinary bladder | 0.0043301160127797 | BEFREE;GAD |
| 1027 | CDKN1B | C0007131 | Non-Small Cell Lung Carcinoma | 0.0041209017631965 | BEFREE |
| 1027 | CDKN1B | C0346647 | Malignant neoplasm of pancreas | 0.0040553892285666 | BEFREE;GAD |
| 1027 | CDKN1B | C0376545 | Hematologic Neoplasms | 0.00383181960166615 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0029463 | Osteosarcoma | 0.00355709281745305 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0079744 | Diffuse Large B-Cell Lymphoma | 0.00355709281745305 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0024305 | Lymphoma, Non-Hodgkin | 0.00328236603323995 | BEFREE;LHGDN |
| 1027 | CDKN1B | C1261473 | Sarcoma | 0.00328236603323995 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0677886 | Epithelial ovarian cancer | 0.0032312088759273 | BEFREE;GAD |
| 1027 | CDKN1B | C0699791 | Stomach Carcinoma | 0.0030219946263441 | BEFREE |
| 1027 | CDKN1B | C0009402 | Colorectal Carcinoma | 0.0030219946263441 | BEFREE |
| 1027 | CDKN1B | C0024623 | Malignant neoplasm of stomach | 0.0030219946263441 | BEFREE |
| 1027 | CDKN1B | C0002395 | Alzheimer's Disease | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0002793 | Anaplasia | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0019196 | Hepatitis C | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0206624 | Hepatoblastoma | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C1292753 | Primary Effusion Lymphoma | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C2363142 | T-Cell Prolymphocytic Leukemia | 0.00300763924902685 | BEFREE;LHGDN |
| 1027 | CDKN1B | C0085215 | Ovarian Failure, Premature | 0.0029564820917142 | BEFREE;GAD |
| 1027 | CDKN1B | C0278996 | Cancer of Head and Neck | 0.0029564820917142 | BEFREE;GAD |
| 1027 | CDKN1B | C0007102 | Malignant tumor of colon | 0.002747267842131 | BEFREE |
| 1027 | CDKN1B | C0029925 | Ovarian Carcinoma | 0.002747267842131 | BEFREE |
| 1027 | CDKN1B | C0699790 | Colon Carcinoma | 0.002747267842131 | BEFREE |
| 1027 | CDKN1B | C2937421 | Prostatic Hyperplasia | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0007124 | Noninfiltrating Intraductal Carcinoma | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0020503 | Hyperparathyroidism, Secondary | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0021390 | Inflammatory Bowel Diseases | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0023267 | Fibroid Tumor | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0023532 | Leukoplakia, Oral | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0027859 | Acoustic Neuroma | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0206695 | Carcinoma, Neuroendocrine | 0.00273291246481375 | LHGDN |
| 1027 | CDKN1B | C0032927 | Precancerous Conditions | 0.0026817553075011 | BEFREE;GAD |
| 1027 | CDKN1B | C0221406 | Pituitary-dependent Cushing's disease | 0.0026817553075011 | BEFREE;GAD |
| 1027 | CDKN1B | C0032002 | Pituitary Diseases | 0.0024725410579179 | BEFREE |
| 1027 | CDKN1B | C0018128 | Graft Occlusion, Vascular | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0027643 | Neoplasm Recurrence, Local | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0085183 | Neoplasms, Second Primary | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0206682 | Follicular thyroid carcinoma | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0206683 | Papillary and follicular adenocarcinoma | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0221002 | Hyperparathyroidism, Primary | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0948480 | Coronary Restenosis | 0.002407028523288 | GAD |
| 1027 | CDKN1B | C0553665 | Skin endocrine disorder | 0.0021978142737048 | BEFREE |
| 1027 | CDKN1B | C0700095 | Central neuroblastoma | 0.0021978142737048 | BEFREE |
| 1027 | CDKN1B | C1527249 | Colorectal Cancer | 0.0021978142737048 | BEFREE |
| 1027 | CDKN1B | C0027819 | Neuroblastoma | 0.0021978142737048 | BEFREE |
| 1027 | CDKN1B | C0235974 | Pancreatic carcinoma | 0.0019230874894917 | BEFREE |
| 1027 | CDKN1B | C0023473 | Myeloid Leukemia, Chronic | 0.0016483607052786 | BEFREE |
| 1027 | CDKN1B | C0023434 | Chronic Lymphocytic Leukemia | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0023452 | Leukemia, Lymphocytic, Acute, L1 | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0152013 | Adenocarcinoma of lung (disorder) | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0598766 | Leukemogenesis | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0684249 | Carcinoma of lung | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0699885 | Carcinoma of bladder | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C1306460 | Primary malignant neoplasm of lung | 0.0013736339210655 | BEFREE |
| 1027 | CDKN1B | C0549473 | Thyroid carcinoma | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C1512409 | Hepatocarcinogenesis | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0007112 | Adenocarcinoma of prostate | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0030521 | Parathyroid Neoplasms | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0149925 | Small cell carcinoma of lung | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0178874 | Tumor Progression | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0302592 | Cervix carcinoma | 0.0010989071368524 | BEFREE |
| 1027 | CDKN1B | C0001430 | Adenoma | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0003873 | Rheumatoid Arthritis | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0004114 | Astrocytoma | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0007847 | Malignant tumor of cervix | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0014132 | Endocrine Gland Neoplasms | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0019829 | Hodgkin Disease | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0023443 | Hairy Cell Leukemia | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0031511 | Pheochromocytoma | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0079731 | B-Cell Lymphomas | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0332996 | Persistent embryonic structure | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0476089 | Endometrial Carcinoma | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0585442 | Osteosarcoma of bone | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C2931456 | Prostate cancer, familial | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C4048328 | cervical cancer | 0.0008241803526393 | BEFREE |
| 1027 | CDKN1B | C0812413 | Malignant Pleural Mesothelioma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0940937 | precancerous lesions | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1290375 | Mesothelioma (malignant, clinical disorder) (disorder) | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1378703 | Renal carcinoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1512981 | Mammary Tumorigenesis | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1708350 | Hereditary Leiomyomatosis and Renal Cell Cancer | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1833929 | THYROID CARCINOMA, SPORADIC MEDULLARY | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C1883486 | Uterine Corpus Cancer | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0002871 | Anemia | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0002893 | Refractory anemias | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0003850 | Arteriosclerosis | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0004153 | Atherosclerosis | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0006413 | Burkitt Lymphoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0007103 | Malignant neoplasm of endometrium | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0019693 | HIV Infections | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0023449 | Acute lymphocytic leukemia | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0023487 | Acute Promyelocytic Leukemia | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0023492 | Leukemia, T-Cell | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0025149 | Medulloblastoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0025322 | Premature Menopause | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0030421 | Paraganglioma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0036220 | Kaposi Sarcoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0039101 | synovial sarcoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0152018 | Esophageal carcinoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0153381 | Malignant neoplasm of mouth | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0220641 | Lip and Oral Cavity Carcinoma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0238462 | Medullary carcinoma of thyroid | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0333186 | Restenosis | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0345967 | Malignant mesothelioma | 0.0005494535684262 | BEFREE |
| 1027 | CDKN1B | C0000744 | Abetalipoproteinemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0002690 | Amputation Stumps | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0005699 | Blast Phase | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0005859 | Bloom Syndrome | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0006118 | Brain Neoplasms | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007104 | Female Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007113 | Rectal Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007120 | Bronchioloalveolar Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007138 | Carcinoma, Transitional Cell | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0007193 | Cardiomyopathy, Dilated | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0008312 | Primary biliary cirrhosis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0008497 | Choriocarcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0008925 | Cleft Palate | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0011847 | Diabetes | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0011849 | Diabetes Mellitus | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0013080 | Down Syndrome | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0014859 | Esophageal Neoplasms | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0016034 | Breast Fibrocystic Disease | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0017661 | IGA Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0020179 | Huntington Disease | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0021400 | Influenza | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0022572 | keratoacanthoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0023440 | Acute Erythroblastic Leukemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0023470 | Myeloid Leukemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0023494 | Leukemia, T-Cell, Chronic | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0024314 | Lymphoproliferative Disorders | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0026010 | Microphthalmos | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0027830 | neurofibroma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0027831 | Neurofibromatosis 1 | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0028945 | oligodendroglioma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0030517 | Parathyroid Diseases | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0038454 | Cerebrovascular accident | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0041107 | Trisomy | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0041296 | Tuberculosis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0042373 | Vascular Diseases | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0042769 | Virus Diseases | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0079745 | Lymphoma, Large-Cell, Follicular | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0079746 | Immunoblastic Large-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0079773 | Lymphoma, T-Cell, Cutaneous | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0079774 | Peripheral T-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0085281 | Addictive Behavior | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0085648 | Synovial Cyst | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0175754 | Agenesis of corpus callosum | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0178664 | Glomerulosclerosis (disorder) | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0206659 | Embryonal Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0206698 | Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0220633 | Uveal melanoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0235653 | Malignant neoplasm of female breast | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0238019 | Carcinoma of extrahepatic bile duct | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0238033 | Carcinoma of Male Breast | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0238122 | Fallopian Tube Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0238339 | Hereditary pancreatitis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0238463 | Papillary thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0242787 | Malignant neoplasm of male breast | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0260037 | Multiple tumors | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0262584 | Carcinoma, Small Cell | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0268731 | Renal glomerular disease | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0271846 | Familial hyperparathyroidism | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0271858 | Tertiary hyperparathyroidism | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0272285 | Heparin-induced thrombocytopenia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0279671 | Cervical Squamous Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0280100 | solid tumor | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0280803 | Primary central nervous system lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0282160 | Aplasia Cutis Congenita | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0333516 | Tumor necrosis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0333873 | Squamous intraepithelial lesion | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0334299 | Carcinoid tumor no ICD-O subtype | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0334317 | Cystadenofibroma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0334471 | Round cell liposarcoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0342637 | Hypocalciuric hypercalcemia, familial, type 1 | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0343641 | Human papilloma virus infection | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0346300 | Pituitary carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0349529 | Gastric Carcinoid Tumor | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0349566 | Squamous cell carcinoma of tongue | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0374997 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0376544 | Hematopoietic Neoplasms | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0399440 | Hereditary gingival fibromatosis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0403592 | Chronic rejection of renal transplant | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0406810 | Carney Complex | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0410207 | Tubular Aggregate Myopathy | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0424605 | Developmental delay (disorder) | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0521158 | Recurrent tumor | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0521720 | Corneal fibrosis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0555198 | Malignant Glioma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0557874 | Global developmental delay | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0740457 | Malignant neoplasm of kidney | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0750952 | Biliary Tract Cancer | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0751396 | Well Differentiated Oligodendroglioma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0853879 | Invasive carcinoma of breast | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0854792 | Resectable Extrahepatic Bile Duct Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0854917 | Rhabdoid Tumor of the Kidney | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0855071 | Primary Synovial Sarcoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C0936223 | Metastatic Prostate Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1258666 | Myxoid cyst | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1301363 | Blastic plasmacytoid dendritic cell neoplasm | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1314694 | Astrocytoma, low grade | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1318485 | Liver regeneration disorder | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1332977 | Childhood Leukemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1334274 | Invasive Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1336527 | Carcinoma of urinary bladder, superficial | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1336548 | Systemic Anaplastic Large Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1367654 | Marginal Zone B-Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1449563 | Cardiomyopathy, Familial Idiopathic | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1512326 | Human T-cell lymphotropic virus 1 infection | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1518869 | Pancreatic Intraductal Papillary-Mucinous Neoplasm | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1519670 | Tumor Angiogenesis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1561643 | Chronic Kidney Diseases | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1654637 | androgen independent prostate cancer | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1704272 | Benign Prostatic Hyperplasia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1709246 | Non-Neoplastic Disorder | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1833921 | Familial medullary thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1834582 | MYELOPROLIFERATIVE SYNDROME, TRANSIENT | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1837218 | Cleft palate, isolated | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1840402 | HYPERPARATHYROIDISM 1 | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1849699 | Progesterone Resistance | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1863340 | PITUITARY ADENOMA PREDISPOSITION (disorder) | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1864729 | HYPERPARATHYROIDISM 3 | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1865285 | Megalencephaly cutis marmorata telangiectatica congenita | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1955745 | Multiple endocrine neoplasia (MEN) Syndrome | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2145472 | Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2676191 | PITUITARY ADENOMA, FAMILIAL ISOLATED (disorder) | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2752147 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2945759 | aggressive cancer | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2981150 | Uranostaphyloschisis | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C2986665 | Early-Stage Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3273239 | Proliferative Inflammatory Atrophy | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3532222 | Inflammatory cardiomyopathy | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3539878 | Triple Negative Breast Neoplasms | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3714524 | Fibromyxosarcoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3805278 | Extrahepatic Cholangiocarcinoma | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3854222 | Human immunodeficiency virus (HIV) II infection category B1 | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3875492 | Hypocalciuric hypercalcemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3888194 | MIXED LINEAGE LEUKEMIA | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C3896960 | Childhood Pre-B Acute Lymphoblastic Leukemia | 0.0002747267842131 | BEFREE |
| 1027 | CDKN1B | C4274947 | Multiple endocrine neoplasia type 4 | 0.0002747267842131 | BEFREE |